Orthofix International

Rank: 82
2016 Rank90
R&D Spend:$28,803,000
Fiscal year ending:12-31-16
Click here to see all 100

Orthofix International is a diversified, global medical device company focused on improving patients' lives by providing superior reconstructive and regenerative orthopedic and spine solutions to physicians worldwide. Headquartered in Lewisville, TX, the company has four strategic business units that include BioStim, Biologics, Extremity Fixation and Spine Fixation. Our products are distributed in more than 50 countries around the world via Orthofix sales representatives, stocking distributors and subsidiaries.

Big 100 Mini Logo Key Personnel: Brad Mason, president & CEO; Doug Rice, CFO; Mike Finegan, chief strategy officer; Kimberly Elting, chief legal officer; Jill Mason, chief ethics & compliance officer; Jim Ryaby, chief scientific officer; Tim McGuire, chief information officer; Brad Niemann, president, biostim; Bob Goodwin, president, biologics; Davide Bianchi, president, extremity fixation; Ray Fujikawa, president, spine fixation; Steve Martin, SVP, operations;

Willemstad, Willemstad
Curazao (Netherlands Antilles)